CLSPF (Canadian Life Split) Research & Development: $0.00 Mil (TTM As of Nov. 2025)


CLSPF Canadian Life Companies Split Corp CLSPF
57 GF Score
Price $5.96
GF Value $4.51
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Canadian Life Split Research & Development?

Canadian Life Split CLSPF 57 Research & Development is $0.00 Mil as of Nov. 2025. GuruFocus rates CLSPF with a GF Score™ of 57/100 and a GF Value™ of $4.51 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Canadian Life Split's Research & Development for the six months ended in Nov. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 was $0.00 Mil.

Canadian Life Split  (OTCPK:CLSPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Canadian Life Split Research & Development Related Terms

Canadian Life Split Research & Development Historical Data

* Premium members only.

The historical data trend for Canadian Life Split's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canadian Life Split Research & Development Chart

Canadian Life Split Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Canadian Life Split Semi-Annual Data
May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CLSPF
57GF Score
Canadian Life Companies Split Corp CLSPF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canadian Life Split Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Canadian Life Split (CLSPF) has a Research & Development of $0.00 Mil as of Nov. 2025. Research and development expense is the total cost for research and development activities. View historical data on Canadian Life Split and its competitors.
Is Canadian Life Split's Research & Development too high?
Canadian Life Split's current Research & Development is $0.00 Mil. Overall, Canadian Life Split has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Canadian Life Split's Research & Development compare to BLK and BX?
Canadian Life Split's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Canadian Life Split and its competitors. Canadian Life Split's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canadian Life Split stock overvalued right now?
Based on GuruFocus' analysis, Canadian Life Split (CLSPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.51, compared to a current price of $5.96 — trading 32.1% above its estimated fair value. The current Research & Development is $0.00 Mil. Canadian Life Split's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Canadian Life Split (CLSPF), the current Research & Development is $0.00 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Canadian Life Split (CLSPF) Overvalued in 2026?

Based on GuruFocus' analysis, Canadian Life Split stock appears to be overvalued. The current stock price of $5.96 is trading 32.1% above its estimated GF Value™ of $4.51. GuruFocus considers Canadian Life Split to be Significantly Overvalued.

Key valuation signals for CLSPF:

  • Research & Development: $0.00 Mil
  • GF Value™: $4.51 vs. price of $5.96 (32.1% above fair value)
  • GF Score™: 57/100 with 8 warning signs

No single metric tells the full story. See the CLSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Canadian Life Split Business Description

Address 200 Front Street West, Suite 2510, P.O. Box 51, Toronto, ON, CAN, M5V 3K2
Canadian Life Companies Split Corp is a mutual fund corporation established in Canada. It invests predominantly in an actively managed portfolio of common shares comprised mainly of four core large capitalization canadian life insurance companies. The company also employs an active covered call writing program to enhance the income earned from the portfolio.
57GF Score

Get the complete analysis for CLSPF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.96
Price
$4.51
GF Value